scispace - formally typeset
Journal ArticleDOI

Quantitative determinants of the outcome of asymptomatic mitral regurgitation

Reads0
Chats0
TLDR
Quantitative grading of mitral Regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation and patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery.
Abstract
background The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. methods We prospectively enrolled 456 patients (mean [±SD] age, 63±14 years; 63 percent men; ejection fraction, 70±8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66±40 ml per beat; effective regurgitant orifice, 40±27 mm 2 ). results The estimated five-year rates (±SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22±3 percent, 14±3 percent, and 33±3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm 2 increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm 2 had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58±9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm 2 , those with an orifice of at least 40 mm 2 had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). conclusions Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm 2 should promptly be considered for cardiac surgery.

read more

Citations
More filters
Journal ArticleDOI

Degenerative Mitral Valve Repair Restores Life Expectancy.

TL;DR: The findings suggest that degenerative MVr restores anticipated life expectancy to that of the general population, regardless of age, while the importance of repair for degenerative mitral disease is underscored.
Journal ArticleDOI

2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations

TL;DR: Valvular heart disease (VHD) is present in ≈2.5% of the general US population, with prevalence increasing to 11.7% to 13.3% in those aged >75 years, and of these, aortic and mitral valvular disease represent 99% of
Journal ArticleDOI

Surgery for asymptomatic degenerative aortic and mitral valve disease.

TL;DR: The case for early pre-emptive intervention in selected, asymptomatic individuals with AS or MR is argued, drawing on contemporary perioperative data, predictors of disease progression, and studies of the natural history of degenerative valvular heart disease.
Journal ArticleDOI

Primary mitral valve regurgitation: Update and review.

TL;DR: This review summarizes the current understanding of primary, degenerative mitral regurgitation with respect to etiology, comprehensive assessment, natural history and management.
Journal ArticleDOI

Predicting Left Ventricular Dysfunction after Surgery in Patients with Chronic Mitral Regurgitation: Assessment of Myocardial Deformation by 2-Dimensional Multilayer Speckle Tracking Echocardiography

TL;DR: STE can be used to predict a decrease in LV function after MVR in patients with chronic severe MR, and could be of use in the clinic when trying to decide upon the optimum time to schedule surgery for such patients.
References
More filters
Journal ArticleDOI

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆

TL;DR: The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death fromComorbid disease for use in longitudinal studies and further work in larger populations is still required to refine the approach.
Journal ArticleDOI

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

TL;DR: It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced in the detection, management, and management of diseases.
Journal ArticleDOI

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

TL;DR: It is the opinion that current technology justifies the clinical use of the quantitative two-dimensional methods described in this article and the routine reporting of left ventricular ejection fraction, diastolic volume, mass, and wall motion score.
Journal ArticleDOI

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

TL;DR: A report from the American Society of Echocardiography’s Nomenclature and Standards Committee and The Task Force on Valvular Regurgitation developed in conjunction with the American College of Cardiology EchOCardiography Committee.
Journal ArticleDOI

Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

TL;DR: Advances in the treatment of hypertension, myocardial ischemia, and valvular heart disease during the four decades of observation did not translate into appreciable improvements in overall survival after the onset of CHF in this large, unselected population.
Related Papers (5)